Ziegler Capital Management LLC acquired a new stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 85,795 shares of the real estate investment trust’s stock, valued at approximately $1,066,000.
→ Fed’s Shocking New Plan to Control Your Money (From Weiss Ratings)
Other institutional investors and hedge funds also recently made changes to their positions in the company. EverSource Wealth Advisors LLC acquired a new position in shares of Sabra Health Care REIT in the third quarter valued at approximately $29,000. Point72 Hong Kong Ltd acquired a new position in shares of Sabra Health Care REIT in the second quarter valued at approximately $31,000. Worth Asset Management LLC acquired a new position in shares of Sabra Health Care REIT in the first quarter valued at approximately $44,000. Wipfli Financial Advisors LLC acquired a new position in shares of Sabra Health Care REIT in the third quarter valued at approximately $90,000. Finally, Silverhawk Asset Management LLC acquired a new position in shares of Sabra Health Care REIT in the fourth quarter valued at approximately $128,000. Institutional investors and hedge funds own 87.20% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on SBRA shares. Citigroup decreased their target price on shares of Sabra Health Care REIT from $13.00 to $10.50 and set a “neutral” rating for the company in a research report on Tuesday, March 28th. Truist Financial decreased their target price on shares of Sabra Health Care REIT from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, March 29th. StockNews.com started coverage on shares of Sabra Health Care REIT in a research report on Thursday, March 16th. They set a “hold” rating for the company. Finally, JMP Securities downgraded shares of Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a research report on Tuesday, December 13th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Sabra Health Care REIT has a consensus rating of “Hold” and a consensus target price of $13.63.
Sabra Health Care REIT Price Performance
Sabra Health Care REIT stock opened at $11.01 on Wednesday. Sabra Health Care REIT, Inc. has a 52-week low of $10.08 and a 52-week high of $16.60. The stock’s 50 day moving average price is $12.12 and its two-hundred day moving average price is $12.60. The company has a debt-to-equity ratio of 0.82, a quick ratio of 3.27 and a current ratio of 3.27.
Sabra Health Care REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 28th. Shareholders of record on Monday, February 13th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 10.90%. The ex-dividend date was Friday, February 10th. Sabra Health Care REIT’s payout ratio is -352.93%.
Sabra Health Care REIT Company Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Health Care REIT, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Sabra Health Care REIT wasn’t on the list.
While Sabra Health Care REIT currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
